If we track the development of TNG from 2014 to the present time focusing on proposed development directions or options, including proposed products and partnerships and all other variables the picture looks like a BOD juggling with about 10 skittles in the air at once.
Throw in the testing to a reliable bankable standard the commercialisation of TIVAN.
Then overlay the cyclic commodity market, spot prices for TNG relevant commodities, down turns in certain economies, the over run in the Aussie mining sector and consequential effect on availability on development finance we see the following;
1) A BOD that has looked at virtually all development options in evolving and economically testing times,
2) Ariving at options and a development plan at an absolutely ideal time with increasing demand for TNGs commodity portfolio,
3) The optimum time for favourable development finance terms and the best possible Shareholder return.
Whether the above is by design or by chance or a combination of both now is the time. The EIS holdup needs to be sorted so that finance terms and final investment decisions can be concluded.
That will provide the related party certainty for MOUs to become binding aggreements, for the likes of EMC and Sumitomo to tender on projects at an early stage, for Wojin to tie down forward deal for Titanium products and on and on.
When the market sees this block cleared and a clear forward path then instos and private investors will pile in knowing TNG has finally derisked and forward NPV can be calculated together with future dividend expectations.
Ironically when we get to this point the delays and "dead money" locked in will acquire a premium and will "have all been worth while" perhaps not completely compensating for lost opportunities but certainly offsetting them.
All my thoughts and all dependant on positive EIS conclusions.
- Forums
- ASX - By Stock
- TVN
- Hurry up TNG
Hurry up TNG, page-6
-
- There are more pages in this discussion • 48 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TVN (ASX) to my watchlist
|
|||||
Last
5.7¢ |
Change
-0.002(3.39%) |
Mkt cap ! $98.20M |
Open | High | Low | Value | Volume |
5.9¢ | 5.9¢ | 5.7¢ | $60.52K | 1.032M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 655737 | 5.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.9¢ | 8153 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 655737 | 0.057 |
6 | 555883 | 0.056 |
4 | 363234 | 0.055 |
2 | 143425 | 0.054 |
1 | 100000 | 0.052 |
Price($) | Vol. | No. |
---|---|---|
0.059 | 8153 | 1 |
0.060 | 64474 | 2 |
0.062 | 228000 | 2 |
0.063 | 100000 | 1 |
0.064 | 175201 | 1 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
TVN (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online